Nature Communications (Jan 2021)

Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

  • Cyrielle Fougeroux,
  • Louise Goksøyr,
  • Manja Idorn,
  • Vladislav Soroka,
  • Sebenzile K. Myeni,
  • Robert Dagil,
  • Christoph M. Janitzek,
  • Max Søgaard,
  • Kara-Lee Aves,
  • Emma W. Horsted,
  • Sayit Mahmut Erdoğan,
  • Tobias Gustavsson,
  • Jerzy Dorosz,
  • Stine Clemmensen,
  • Laurits Fredsgaard,
  • Susan Thrane,
  • Elena E. Vidal-Calvo,
  • Paul Khalifé,
  • Thomas M. Hulen,
  • Swati Choudhary,
  • Michael Theisen,
  • Susheel K. Singh,
  • Asier Garcia-Senosiain,
  • Linda Van Oosten,
  • Gorben Pijlman,
  • Bettina Hierzberger,
  • Tanja Domeyer,
  • Blanka W. Nalewajek,
  • Anette Strøbæk,
  • Magdalena Skrzypczak,
  • Laura F. Andersson,
  • Søren Buus,
  • Anette Stryhn Buus,
  • Jan Pravsgaard Christensen,
  • Tim J. Dalebout,
  • Kasper Iversen,
  • Lene H. Harritshøj,
  • Benjamin Mordmüller,
  • Henrik Ullum,
  • Line S. Reinert,
  • Willem Adriaan de Jongh,
  • Marjolein Kikkert,
  • Søren R. Paludan,
  • Thor G. Theander,
  • Morten A. Nielsen,
  • Ali Salanti,
  • Adam F. Sander

DOI
https://doi.org/10.1038/s41467-020-20251-8
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 11

Abstract

Read online

Here the authors generate a capsid-like particle based vaccine candidate displaying the receptor-binding domain of the SARS-CoV-2 spike protein and show induction of neutralizing antibodies after intramuscular prime-boost immunization in mice.